Category Archives: Health

Study Highlights Early Health Risks in Children Born Prematurely

A comprehensive longitudinal study by researchers at Vilnius University’s Faculty of Medicine reveals that nearly 80 per cent of all medical diagnoses in children born prematurely are identified before the age of seven, underscoring the urgent need for early, long-term and personalised follow-up care.

Led by Dr Rūta Morkūnienė and Prof. Dr Janina Tutkuvienė, the research traces health trajectories from birth through adolescence and into adulthood, demonstrating that the impact of prematurity extends far beyond the neonatal period. The findings carry global relevance: according to the World Health Organization, an estimated 15 million babies are born preterm each year worldwide. While survival rates have improved significantly, the study challenges the assumption that prematurity-related health issues are limited to infancy, highlighting instead a prolonged and evolving health burden.

Most health risks emerge early in life

One of the most extensive analyses of long-term outcomes in preterm children conducted in Lithuania to date, the study draws on medical records from primary healthcare institutions to map health patterns from birth through adolescence.

Unlike many previous studies, the researchers did not restrict their analysis to conditions traditionally linked to prematurity, such as respiratory or neurological disorders.

“I did not set out to record only diagnoses already described in the literature as typical for preterm children,” explains Dr Morkūnienė, a physician and lecturer at Vilnius University. “I documented everything that each child accumulated over time. What emerged was a very broad spectrum of conditions, often involving multiple organ systems and differing greatly from one child to another.”

The findings show that children born prematurely experience a substantially higher overall disease burden than those born at term. Congenital anomalies, nervous system and mental health disorders, tumours, and diseases of the urinary and reproductive systems were diagnosed three to four times more often than in the general population. Disorders of the immune and blood systems occurred up to ten times more frequently, indicating vulnerabilities that persist well beyond early childhood.

A critical window from birth to age seven

Perhaps the study’s most striking insight relates to the timing of diagnosis.

“More than 45 per cent of all diagnoses are made during the first three years of life,” notes Dr Morkūnienė, “and over 30 per cent more are identified between the ages of three and seven.”

By the age of seven, children born prematurely have already accumulated nearly 80 per cent of all diagnoses they are likely to receive by adulthood. The heaviest disease burden falls on children born with very low birth weight (below 1,500 grams), who not only develop more health conditions overall but also a wider range of them.

“Even children born at the same gestational age and with the same birth weight can follow very different health trajectories,” Dr Morkūnienė adds. “Still, the most premature and smallest infants tend to accumulate both more numerous and more diverse health problems.”

Birth weight outweighs gestational age

A key methodological strength of the study lies in its decision to analyse birth weight and gestational age separately, rather than combining them into a single indicator. This distinction revealed that birth weight is more strongly associated with long-term disease burden than gestational age alone.

Children born with lower birth weight grew more slowly and remained shorter and lighter than their peers into adolescence. While their body mass index (BMI) was initially lower, it began to rise sharply from around the age of nine, eventually surpassing that of children born at term.

“This pattern is increasingly recognised internationally,” explains Prof. Tutkuvienė. “Children born prematurely face a higher risk of long-term metabolic conditions, including obesity and diabetes. By analysing birth weight and prematurity separately, we were able to identify which factor plays a more significant role in specific metabolic processes—one of the key novelties of our research.”

Why population-specific growth standards matter

Beyond individual outcomes, the study highlights a broader challenge in paediatric care: the reliance on outdated or poorly adapted growth standards.

“Until recently, Lithuania did not have head circumference reference values for newborns,” says Dr Morkūnienė. “Height and weight standards were often based on limited or decades-old data.”

Using advanced statistical methods developed by Prof. Tim Cole of the UCL Institute of Child Health, the research team established new, population-specific growth norms for Lithuanian newborns, including preterm infants. While international standards are useful for comparison, the researchers warn that they may misrepresent clinically meaningful thresholds in specific populations, potentially leading to delayed or inaccurate diagnoses.

Survival is not the endpoint

Survival outcomes for preterm infants have improved dramatically. In Lithuania, nine out of ten children born prematurely now survive, placing the country among the global leaders in neonatal care. However, the researchers stress that survival alone should not be viewed as the endpoint.

“Prematurity is not a life sentence,” emphasises Prof. Tutkuvienė. “The human body is remarkably resilient. What truly matters is whether health systems provide timely, personalised and long-term support that allows children to reach their full potential.”

Children born preterm, the researchers argue, require extended, multidisciplinary follow-up, involving not only neonatologists and neurologists but also psychologists, speech therapists, physiotherapists and other specialists who can monitor physical, cognitive and emotional development.

“Early childhood is a period of exceptional developmental flexibility,” says Dr Morkūnienė. “When difficulties are identified early, targeted interventions can make a profound difference. Timely support during these formative years can significantly shape long-term health and wellbeing.”

RevealDx Receives FDA Clearance for AI-Powered Lung Nodule Risk Assessment

Seattle, WA – Feb 04: RevealDx, a leader in artificial intelligence solutions for lung nodule characterization, today announced that it has received U.S. Food and Drug Administration (FDA) clearance for RevealAI-Lung, its AI-powered lung nodule risk assessment software. The announcement follows the company’s MDR Certification, received in November 2025.

RevealAI-Lung is designed to assist radiologists in the evaluation of incidental lung nodules by generating a Malignancy Similarity Index (mSI™)—a clinically relevant score that supports more informed follow-up recommendations and aids in earlier and more accurate cancer diagnosis. The technology has been validated on data from more than 1,500 patients across diverse clinical cohorts.

The RevealAI-Lung CADx device offers several differentiated capabilities, including:

• Significant improvement in radiologist reader performance (AUC delta)

• Use of real-world National Lung Screening Trial (NLST) data as the reference population

• Clinically meaningful malignancy risk scoring

• Industry-first direct integration into PACS, enabling seamless workflow integration

• Strong generalizability across exam types and patient populations

RevealAI-Lung is available for purchase directly from RevealDx or through its U.S. distributor, Sirona. The company has also announced integrations with Riverain, the leading lung nodule detection company in the U.S., as well as FUJIFILM PACS, further expanding clinical accessibility.

With FDA clearance, RevealAI-Lung is now eligible for Medicare reimbursement under CPT codes 0721T and 0722T, supporting broader clinical adoption.

Commenting on the milestone, Chris Wood, CEO of RevealDx, said,

“We are excited to announce that RevealAI-Lung is now available in the United States. We would like to thank our clinical collaborators for their invaluable support in achieving this milestone. Most importantly, we are enthusiastic about the positive impact RevealAI-Lung can have on patient care by enabling more confident and timely clinical decision-making.”

Budget 2026 Boosts Healthcare Access, Infrastructure, and Skilled Workforce

By:- Dr. Azad Moopen, Founder & Chairman, Aster DM Healthcare

Today’s Budget lays out a thoughtful and forward-looking blueprint for India’s healthcare ecosystem—one that seamlessly integrates innovation, access, capacity expansion and global competitiveness. The Biopharma Shakti initiative, with an outlay of ₹10,000 crore over five years and a clear focus on strengthening research, manufacturing and regulatory capabilities, will play a pivotal role in accelerating India’s journey towards advanced, affordable and globally benchmarked healthcare solutions. The exemption of basic customs duty on 17 critical cancer drugs is a timely and patient-centric measure that will significantly improve access to life-saving therapies while easing the financial burden on families.

The Budget’s strong emphasis on healthcare infrastructure is equally encouraging. The proposed 50 percent capacity expansion of district hospitals, combined with targeted investments in tertiary care through the expansion of NIMHANS 2.0 in North India and the addition of three new AIIMS facilities, will meaningfully strengthen care delivery across both urban and underserved regions. These measures reinforce the government’s commitment to building a more resilient, inclusive and future-ready public health system.

Importantly, the Budget recognises healthcare as a powerful engine of employment and social impact. The announcement of 1,00,000 Allied Health Professionals (AHPs), alongside the training of 1.5 lakh caregivers, supported by structured skilling initiatives, AI-enabled training pathways and digital health programmes, marks a decisive step towards building a large, skilled and future-ready healthcare workforce. This integrated approach will help support an ageing population, specialised care needs and emerging models of care delivery. Together with the continued push for medical hubs, medical value tourism, and a sharper focus on mental and digital health, these initiatives firmly position India as a globally trusted healthcare destination with sustainable long-term growth potential.

Budget 2026: Healthcare Industry Welcomes Focus on Research, Trauma Care, and AYUSH-Integrated Medical Hubs

New Delhi, Feb 01: The Union Budget 2026 has been widely welcomed by India’s healthcare industry for its strategic emphasis on long-term preparedness, research, emergency care, and integrated healthcare systems. Industry leaders highlight that the measures announced in the Budget position India as a global hub for advanced, affordable, and holistic healthcare.

Dr. (Prof.) Purshotam Lal, Chairman, Metro Group of Hospitals, said,

“The ₹10,000 crore commitment to establish a national Biopharma Hub and strengthen non-communicable disease control is both timely and visionary. The proposal to set up trauma centres in every district hospital will enhance emergency response, particularly in semi-urban and rural areas. The creation of 1,000 accredited clinical trial sites bridges the gap between innovation and patient access, while regulatory strengthening enhances India’s credibility in global healthcare.”

Echoing this view, Mr. Abhishek Kapoor, CEO, Regency Healthcare, stated,

“Budget 2026 builds a framework for a more balanced healthcare ecosystem by investing in district-level infrastructure, expanding clinical research networks, and addressing the shortage of allied healthcare professionals. This integrated approach ensures that advanced care and innovation are accessible beyond major urban centres, improving patient outcomes and trust in both public and private healthcare systems.”

Dr. Sharan Shivaraj Patil, Chairman, SPARSH Group of Hospitals, added,

“The establishment of five new Medical Hubs integrated with AYUSH centres marks a major boost for medical tourism and the ‘Heal in India’ initiative. By linking infrastructure, research, and system-wide capacity building, the Budget strengthens India’s position as a global destination for high-quality, affordable treatment.”

Dr. Alok Khullar, Group CEO, RJ Corp Healthcare, commented,

“Budget 2026 demonstrates a strategic vision for healthcare as a driver of economic growth. Expanding clinical trial networks and streamlining regulatory processes will accelerate innovation, improve patient access to advanced therapies, and strengthen India’s global healthcare credibility.”

Mr. Baldev Raj, Founder & CEO, Prius Healthcare, and Vice Chairman, Public Relations Council of India (Delhi Chapter), said,

“The integration of AYUSH centres within five Medical Hubs signals a new era where healthcare is not only a social sector but a pillar of economic growth and global competitiveness. The Budget ensures that infrastructure, skilled manpower, and innovation converge to build a trusted, world-class healthcare system that extends beyond metropolitan centres.”

Key Highlights Welcomed by Industry Leaders:

• ₹10,000 crore for a national Biopharma Hub and non-communicable disease control

• Trauma centres in every district hospital to enhance emergency care

• 1,000 accredited clinical trial sites to accelerate research and innovation

• Integration of AYUSH centres within five new Medical Hubs to boost medical tourism

• Emphasis on allied healthcare professionals and skill development

• Regulatory strengthening to improve compliance, safety, and global credibility

Collectively, these measures are expected to improve healthcare access in Tier-2 and Tier-3 cities, strengthen India’s research and medical tourism capabilities, and reinforce the country’s position as a global healthcare leader.

KIMS Kurnool doctors Dr. Sheikh Mannan & Dr. Kiran Kumar who corrected S-shaped spine

Kurnool, Jan 31: Doctors at KIMS Hospital, Kurnool, have successfully corrected a severe S-shaped spinal deformity in an 18-year-old girl through a highly complex surgery involving the placement of 30 spinal screws.

The patient, a resident of Vamasamudram village in Kurnool district, had been suffering for several years from persistent headaches, abnormal gait, and progressive spinal curvature. Her family, belonging to an economically weaker background, initially sought treatment at a private hospital where she underwent surgery in 2019 for Arnold–Chiari malformation, a congenital condition affecting the brain. While the headaches subsided after that procedure, the spinal deformity continued to worsen over the years, eventually resulting in a pronounced hunchback posture.

Given the high risk associated with corrective spinal surgery in such cases, including the possibility of permanent neurological damage, the patient was referred to KIMS Hospital, Kurnool.

After detailed evaluation, a team led by consultant spine surgeon Dr. Shaik Mannan and Chief Consultant and Head of the Orthopaedics Department Dr. Kiran Kumar decided to perform the surgery under continuous intra-operative neuromonitoring.

Explaining the procedure, Dr. Mannan said the patient had a spinal curvature of nearly 50 degrees extending from the D2 to L4 vertebrae.

“Despite the high risk, we were able to achieve nearly 90–95% correction using 30 specialised screws. The spinal alignment has been restored close to normal. The earlier shoulder imbalance has resolved, both shoulders are now at the same level, and the prominent bony hump on the back has significantly reduced,” he said.

Remarkably, the patient was able to walk independently from the first day after surgery, and her vital functions returned to normal soon after. The surgery was successfully completed with the support of the anaesthesia team comprising Dr. Bhuvana and Dr.Shruthi, along with, critical care Dr. Rajesh Reddy.

Orthopaedic HOD Dr. Kiran Kumar said the procedure marked one of the most complex spinal surgeries performed in the Rayalaseema region and the first successful neuromuscular scoliosis correction of its kind in the area. “This achievement once again highlights the clinical expertise and commitment of KIMS Hospital,” he noted.

KIMS Kurnool Regional COO Siddareddy stated that the entire cost of the surgery was covered under the Arogyasri scheme, making it completely free for the patient. He added that the hospital has performed over 100 highly complex spinal surgeries in the Rayalaseema region, which he described as a matter of pride for the institution.

HPV Vaccination and Regular screening can prevent cervical cancer

Mohali, Jan 31: Cervical cancer is the second most common cancer affecting Indian women, with nearly 1.3 lakh women diagnosed every year. Sadly, most women in India are diagnosed in advanced stages leading to high death rates. This is truly unfortunate as cervical cancer is a preventable cancer. With January being observed as the Cervical Cancer Awareness Month, Dr Shweta Tahlan, Senior Consultant, Gynae Onco-Surgery, Fortis Hospital, Mohali, gives us a detailed insight on cervical cancer.

Cervical cancer occurs in the cells of the cervix, which is the lower part of uterus and most cases are reported in the age group of 35-60 years. Majority of cervical cancers are caused by persistent infection by high-risk strains of Human papilloma virus, and a precancer stage usually precedes the invasive cancer stage. This detailed understanding of the disease makes it a preventable cancer

Prevention and Early detection

HPV vaccination provides the primary prevention against this deadly disease and timely vaccination gives lifelong protection. The recommended age to get vaccinated is between 9 and 26 years of age, although, it can also be given to women up to 45 years of age. HPV vaccine is very safe, effective, widely available and affordable. HPV vaccination is recommended by all medical organizations like WHO, FOGSI and IAP.

Screening tests provide secondary prevention, and it is done by testing cervical smears for abnormal cells (Pap smear & LBC) and presence of HPV (HPV testing). The test is painless and is done in OPD itself. This helps us detect and cure women in precancer stage itself (before cancer is formed). Screening test is recommended for all women over the age of 25 years.

Early detection helps detect women in early stages of cancer. Symptoms of cervical cancer are postcoital vaginal bleeding, persistent vaginal discharge which can be foul-smelling or blood stained, postmenopausal vaginal bleeding, continuous or intermenstrual bleeding, lower abdomen pain or discomfort, urinary troubles and severe back ache.

Treatment

Women in early stages are treated effectively by radical surgery and women diagnosed in advanced stages are treated with radiotherapy, chemotherapy and immunotherapy. Timely treatment from expert oncologists can provide good survival and excellent quality of life.

Widespread HPV vaccination and regular screening can help save many lives. Our target is to save women from this deadly disease and together, we can achieve it.

ISIC Expands Advanced Care with Launch of Integrated Sports Injury Clinic

New Delhi, January 30, 2026: ISIC Multispecialty Hospital, has further strengthened its advanced care portfolio with the launch of a dedicated Sports Injury Clinic—a first-of-its-kind, fully integrated centre designed to deliver comprehensive, patient-centric sports injury management.

Going beyond conventional treatment models, the clinic combines professional movement and biomechanical assessments with advanced diagnostics to identify underlying “weak links” in the body that contribute to injury or recurrence. The medical team deploys non-invasive and minimally invasive interventions, including Arthroscopy, Minimally Invasive Spine Surgery (MISS), Platelet-Rich Plasma (PRP), Stem Cell Therapy/BMAC, and Prolotherapy, ensuring precision-led treatment, faster recovery, and durable outcomes. From prehabilitation and accurate diagnosis to surgical excellence and data-driven rehabilitation, the clinic offers a truly end-to-end care ecosystem.

Built on the philosophy that movement is medicine, the Sports Injury Clinic integrates cutting-edge technology with expert-led clinical care to optimise recovery and performance. Central to this approach is the TecnoBody Digital Movement Laboratory, featuring a Digital Mirror Wall, 3D cameras, and real-time biofeedback that provide instant visual cues to correct posture and movement during therapy. Walker View Gait Analysis evaluates walking and running mechanics to identify imbalances and improve posture, while ProKin Balance Platforms deliver advanced proprioceptive training—critical for recovery from injuries such as ankle sprains and ACL tears.

The clinic’s capabilities are further strengthened by hydrotherapy, low-impact recovery programmes, advanced robotics, and 7K visualisation systems, enabling enhanced precision and safety across interventions. Rehabilitation is delivered exclusively by Masters-level physiotherapists, using advanced neuromuscular training techniques, supported by naturopathy and evidence-based clinical nutrition to accelerate healing, optimise performance, and build long-term resilience.

The launch comes at a time when sports-related injuries are rising steadily across India. Studies suggest that nearly half of individuals engaged in regular physical activity experience musculoskeletal injuries, most commonly affecting the knees (28%), ankles (18%), shoulders (10%), and spine (13%). Notably, ACL injuries among young athletes have surged by over 400% in the past two decades, driven by early sports specialisation and inadequate rehabilitation. Experts highlight that the lack of integrated sports medicine infrastructure often results in incomplete recovery, repeated injuries, and shortened athletic careers—gaps the ISIC Sports Injury Clinic aims to address.

Commenting on the launch, Ms. Sugandh Ahluwalia, Chief Strategy Officer, ISIC Multispecialty Hospital, said,
“ISIC’s legacy has always been rooted in restoring movement and function through advanced spine and orthopaedic care. The Sports Injury Clinic is a natural extension of this philosophy, where prehabilitation and rehabilitation are not add-ons but central to recovery. By integrating early conditioning, precise movement analysis, and masters-led rehabilitation, we are enabling athletes to be better prepared before injury or surgery and supported well beyond it—ensuring recovery that is stronger, safer, and sustainable.”

Dr. Ashish Chandra, Chief Operating Officer, ISIC Multispecialty Hospital, added,
“As ISIC continues to evolve, our focus remains on building advanced, future-ready centres of care. The Sports Injury Clinic reflects this vision—bringing together minimally invasive surgery, robotic rehabilitation, digital motion labs, hydrotherapy, and regenerative therapies under one roof. This integrated ecosystem allows us to offer athletes access to sports medicine and recovery protocols on par with leading global institutions.”

With the launch of the Sports Injury Clinic, ISIC Multispecialty Hospital reinforces its position as a centre of excellence in advanced orthopaedic and sports medicine care, offering athletes a comprehensive, future-ready platform dedicated to recovery, performance, and long-term athletic health.

Budget 2026 Can Strengthen Early and Accessible Fertility Care: Abhishek Aggrawal

Abhishek Aggrawal, CEO, Birla Fertility & IVF

“India’s health system has made significant progress in prevention, diagnostics, and treatment. Fertility care now needs to be formally integrated into this framework as part of comprehensive family health planning.

Budget 2026 has an opportunity to enable earlier and more efficient fertility care through practical measures. Integrating fertility screening into preventive health programmes and extending insurance coverage to diagnostics and early stage interventions would allow people to seek care sooner, when treatment is more effective and costs are better controlled.

Access must be matched with quality. National standards for fertility laboratories, structured training for embryologists, and consistent clinical protocols are essential to delivering safe and reliable outcomes across the country.

These are targeted investments with long term returns. Strong fertility care infrastructure supports family formation, demographic stability, and a more resilient healthcare system, making it a logical inclusion in India’s health and economic planning.”

Kauvery Hospital Treats Rare Pancreatic Tumour Using Advanced Technology After Patient Presents with Giddiness

Chennai, Jan 29: Kauvery Hospital, Vadapalani, successfully diagnosed a rare and elusive pancreatic tumour known as an insulinoma in a 60-year-old woman, causing persistently low blood sugar and frequent loss of consciousness.

The hospital followed a stepwise diagnostic approach. Initial imaging studies, including a contrast CT scan and a specialised PET scan, did not clearly identify the cause. The breakthrough came with specialised blood tests measuring insulin and C-peptide levels, followed by a targeted endoscopic ultrasound (EUS), which ultimately helped locate the tumour.

The tumour’s small size and challenging location added a further layer of complexity. Measuring just 1.3 cm, it was located at the neck of the pancreas and surrounded by vital structures. The surgical team therefore opted for a robotic-assisted approach, using robotic intraoperative ultrasound (RIOUS) to accurately localise and safely remove the tumour.

The surgery was successful, with the patient’s blood sugar levels started normalising immediately after the procedure. She made a rapid recovery and was able to return to normal activity the very next day.

The diagnostic team was led by Dr. P. Basumani, Senior Consultant and Director, Kauvery Institute of Digestive Sciences, Kauvery Hospital, Vadapalani, while the robotic procedure was performed by Dr. Swaminathan Sambandam, Senior Consultant and Lead, Multi-Organ Transplant (Liver, Kidney, Pancreas and Small Intestine), Kauvery Hospital, Vadapalani.

In his comments Dr.  Basumani said,

“Insulinomas are extremely difficult to locate, especially when they are very small. In this case, even advanced imaging did not give us clear answers. Specialised blood tests combined with focused Endoscopic Ultrasound Evaluation helped us precisely identify the tumour.”

Dr. Swaminathan Sambandam said,

“This was a technically demanding surgery. Tumours of this size and location are extremely challenging to operate on through conventional methods. Robotic surgery, supported by intraoperative ultrasound, gave us unmatched precision and control. Very few hospitals in the country have access to this level of technology.”

In his comments, Dr Aravindan Selvaraj, Co-founder and Executive Director, Kauvery Group of Hospitals, said,

“This case reflects the strength of clinical teamwork, perseverance in diagnosis, and the role of advanced technology in handling rare pancreatic and endocrine tumours. It reinforces Kauvery Hospital’s commitment to clinical excellence, advanced diagnostics and state-of-the-art robotic surgery”.

Cervical Cancer awareness month: Tata AIA Health Buddy makes prevention simple and accessible for Families

Bangalore, Jan 29: Cervical cancer is often silent, undetected, and devastating. But what if the story could be changed? What if prevention was within reach—right now?

Cervical cancer: A preventable crisis

Cervical cancer is the second most common cancer among women in India, responsible for nearly 20% of all female cancer cases. The good news is that 90% of these cases are preventable with timely vaccination and screening. Yet, fewer than 2% of women between 30–49 have ever been screened. This isn’t due to a lack of concern, but because many women lack the access, awareness, and support to act early. The solution is simple, taking an HPV (Human Papillomavirus vaccine) in advance as a preventive measure.

Prevention Starts with Early Action

What if families could act before cervical cancer even has a chance? Tata AIA Health Buddy empowers families to take control of their health. With easy access to HPV vaccination as part of Health Buddy benefits, our consumers can ensure they are protected from cervical cancer, that too at discounted rates. Tata AIA removes the hassle of external appointments and complicated procedures, enabling families to act when it matters most.

Sujeet Kothare, Chief of Products, Marketing, Corporate Communications & Business Mid Office, Tata AIA Life Insurance said,

 “Cervical cancer remains a significant threat to women’s health in India, but prevention is within our control. Taking proactive steps, such as the HPV vaccination, can help protect future generations. At Tata AIA, we are committed to empowering women with the tools they need to live healthy lives. Through our Tata AIA Health Buddy benefits, we offer exclusive discounts on HPV vaccinations, reinforcing our dedication to the well-being of the communities we serve. Together, we can make a lasting impact in the fight against cervical cancer.”

More than just Vaccination: Comprehensive support at every step

Cervical cancer prevention is just the beginning. Tata AIA Health Buddy is designed to support families throughout their health journeys:

• Doctor Consultations: Easy access to expert advice when needed.
• Health Check-ups: Regular monitoring to stay ahead of health needs.
• Medical Second Opinions & Case Management: Dedicated support for families during critical health challenges.
• Extra Savings: Discounts on prescribed medicines and lab tests.

These services aren’t just about convenience—they’re about giving families the tools to make informed decisions and the peace of mind that comes with knowing they are supported at every step of the way.

Real benefits for the Whole Family

Health decisions affect the entire family. Whether it’s a mother, wife, sister, or daughter, caring for loved ones is a shared responsibility. With Tata AIA Health Buddy, the whole family has access to crucial health services, empowering them to stay healthy. And it’s not just policyholders who benefit; Tata AIA extends these services to nominees and family members as well.

Shifting the Focus: Life Insurance that cares about Health

What if life insurance was about more than just financial protection? What if it was about proactive care, early action, and long-term health management? Tata AIA is shifting the paradigm. With Tata AIA Health Buddy, the company is not only protecting families’ financial futures—it’s helping them stay healthy, stay informed, and take charge of their well-being every step of the way.